Enhanced Stimulation of Anti-Ovarian Cancer CD8+ T Cells by Dendritic Cells Loaded with Nanoparticle Encapsulated Tumor Antigen
Authors:
- 18 January 2011
- journal article
- research article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 65 (6) , 597-609
Abstract
Citation Hanlon DJ, Aldo PB, Devine L, Alvero AB, Engberg AK, Edelson R, Mor G. Enhanced stimulation of anti‐ovarian cancer CD8+ T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen. Am J Reprod Immunol 2011; 65: 597–609 Problem Dendritic cell (DC)‐based cancer therapies are favored approaches to stimulate anti‐tumor T‐cell responses. Unfortunately, tolerance to tumor antigens is difficult to overcome. Biodegradable poly(lactic‐co‐glycolic acid) (PLGA) nanoparticles (NP) are effective reagents in the delivery of drugs and tumor‐associated antigens (TAA). In this study, we assessed the capacity of a PLGA NP‐based delivery system to augment CD8 T‐cell responses to ovarian cancer TAA. Method of Study Human DC were generated from blood monocytes by conventional in vitro differentiation and loaded with either soluble tumor lysate or NP/lysate conjugates (NPL). These antigen‐loaded DC were then used to stimulate autologous CD8+ T cells. Cytokine production and activation markers were evaluated in the CD8+ T cells. Results DC loading with NPL increased cytokine production by stimulated CD8 T cells and induced T‐cell expression of cell surface co‐stimulatory molecules, typical of anti‐tumor immune responses. In contrast, delivery of naked tumor lysate antigens preferentially induced a T‐cell profile characteristic of tolerization/exhaustion. Conclusion These findings indicate that delivery of TAA in NP enables DC to efficiently activate anti‐tumor CD8+ T cells. PLGA NP encapsulation of tumor‐derived lysate protein antigens is an encouraging new preparative methodology for DC‐based vaccination meriting clinical testing.Keywords
This publication has 62 references indexed in Scilit:
- Melanoma-Associated Antigen Expression in Lymphangioleiomyomatosis Renders Tumor Cells Susceptible to Cytotoxic T CellsThe American Journal of Pathology, 2009
- Genetic Modification of T Cells With IL-21 Enhances Antigen Presentation and Generation of Central Memory Tumor-specific Cytotoxic T-lymphocytesJournal of Immunotherapy, 2009
- Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyVaccine, 2009
- Adoptive cell therapy for the treatment of patients with metastatic melanomaCurrent Opinion in Immunology, 2009
- Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumBritish Journal of Cancer, 2009
- Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cellsOncogene, 2008
- Relative contribution of direct and indirect allorecognition in developing tolerance after liver transplantationLiver Transplantation, 2008
- Dendritic cell subsets in lymph nodes are characterized by the specific draining area and influence the phenotype and fate of primed T cellsImmunology, 2008
- REVIEW ARTICLE: Harnessing the Immune System for Ovarian Cancer TherapyAmerican Journal of Reproductive Immunology, 2007
- Immunological responses can have both pro- and antitumour effects: implications for immunotherapyExpert Reviews in Molecular Medicine, 2007